je.st
news
U.S. FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen...
2013-12-14 19:29:39| Biotech - Topix.net
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera for use in certain virologically-suppressed and St. John's wort.
Tags: single
tablet
fda
approves
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||